Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$16.13 - $26.99 $1.3 Million - $2.17 Million
-80,419 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$13.55 - $21.3 $286,230 - $449,941
-21,124 Reduced 20.8%
80,419 $1.33 Million
Q4 2017

Feb 14, 2018

SELL
$12.12 - $21.65 $2.1 Million - $3.76 Million
-173,457 Reduced 63.08%
101,543 $1.92 Million
Q3 2017

Nov 14, 2017

BUY
$11.94 - $14.29 $3.28 Million - $3.93 Million
275,000
275,000 $3.37 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $235M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Park West Asset Management LLC Portfolio

Follow Park West Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park West Asset Management LLC with notifications on news.